Luminex Plc (COSE:LUMX.N0000)

Intercept Pharmaceuticals Balance Sheet

Financials in millions LKR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	351	153.18	198.45	171.15	61.3
Short-Term Investments	-	267.91	249.72	182.83	318.43
Cash & Short-Term Investments	351	421.09	448.17	353.98	379.73
Cash Growth	-16.64%	-6.04%	26.61%	-6.78%	22.02%
Accounts Receivable	744.65	435.07	756.48	1,342	465.22
Other Receivables	37.23	34.51	37.46	12.28	14.33
Receivables	781.88	1,111	829.27	1,355	480.49
Inventory	852.64	868.72	1,047	1,387	546.85
Prepaid Expenses	-	2.4	2.8	1.41	-
Other Current Assets	515.78	107.11	304.09	81.56	159.57
Total Current Assets	2,501	2,510	2,632	3,179	1,567
Property, Plant & Equipment	208.92	225.34	282.3	361.53	338.38
Long-Term Investments	-	216.97	159.2	-	-
Other Intangible Assets	0.22	0.69	0.95	2.2	3.44
Long-Term Deferred Tax Assets	11.54	5.49	-	-	1.82
Other Long-Term Assets	49.93	52.06	108.11	51.34	21.45
Total Assets	2,772	3,441	3,786	3,594	1,932
Accounts Payable	521.04	61.35	79.68	199.12	37.49
Accrued Expenses	-	94.62	134.47	56.95	60.95
Short-Term Debt	215.64	244.08	387.04	990.04	160.66
Current Portion of Long-Term Debt	95.97	548.73	15.72	9.02	4.67
Current Portion of Leases	-	20.61	36.26	47.6	41.05
Current Income Taxes Payable	-	27.25	39.91	67.43	36.51
Current Unearned Revenue	-	-	1.75	5.43	9.78
Other Current Liabilities	-0	126.41	344.98	224.04	19.63
Total Current Liabilities	832.65	1,123	1,040	1,600	370.73
Long-Term Debt	37.33	171.65	555.59	43.84	5
Long-Term Leases	-	16.14	30.37	63.78	57.86
Long-Term Deferred Tax Liabilities	-	-	1.19	9.37	-
Other Long-Term Liabilities	-	-	-	-	0.01
Total Liabilities	935.18	1,369	1,670	1,751	493.76
Common Stock	450	450	450	200	200
Retained Earnings	1,412	1,622	1,644	1,643	1,238
Comprehensive Income & Other	-23.33	-13.27	-9.71	-	-
Total Common Equity	1,839	2,059	2,085	1,843	1,438
Minority Interest	-1.94	12.93	31.83	-	-
Shareholders' Equity	1,837	2,072	2,116	1,843	1,438
Total Liabilities & Equity	2,772	3,441	3,786	3,594	1,932
Total Debt	348.94	1,001	1,025	1,154	269.23
Net Cash (Debt)	2.06	-580.13	-576.8	-800.3	110.5
Net Cash Per Share	0.01	-2.14	-2.17	-4.80	0.46
Filing Date Shares Outstanding	271.25	271.25	271.25	271.25	240
Total Common Shares Outstanding	271.25	271.25	271.25	240	240
Working Capital	1,669	1,387	1,592	1,579	1,196
Book Value Per Share	6.78	7.59	7.69	7.68	5.99
Tangible Book Value	1,838	2,058	2,084	1,840	1,435
Tangible Book Value Per Share	6.78	7.59	7.68	7.67	5.98
Land	-	81.8	81.8	81.8	112.68
Buildings	-	21.79	21.79	21.79	17.76
Machinery	-	493.68	541.39	543.43	467.29
Construction In Progress	-	-	-	1.06	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.